Neovascular age‐related macular degeneration treated with ranibizumab or aflibercept in the same large clinical setting: visual outcome and number of injections
Sign Up to like & getrecommendations! Published in 2017 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13233
Abstract: To study visual outcome and number of annual injections in treatment‐naïve patients with neovascular age‐related macular degeneration (nAMD) before and after a change in first‐line therapy from ranibizumab to aflibercept in a high‐volume clinical practice. read more here.
Keywords: outcome number; macular degeneration; age related; related macular ... See more keywords